In this video interview recorded at Heart Rhythm 2012, Dr. Eric Prystowsky tackled the controversial topic of rate control vs. rhythm control for treating atrial fibrillation, and knowing whether you are symptomatic or asymptomatic. He also discussed the issues related to leaving afib patients on rate control long term, such as the buildup of fibrosis …
Read More
At Heart Rhythm 2012, Dr. Albert Waldo shared with StopAfib.org’s Mellanie True Hills about why aspirin should no longer be used for the prevention of stroke in atrial fibrillation. Dr. Waldo noted that many global afib guidelines have been revised, or soon will be, to remove aspirin as a recommended atrial fibrillation stroke prevention treatment. …
Read More
At Heart Rhythm 2012, Dr. Sanjiv Narayan gave us an update on his FIRM (focal impulse and rotor modulation) ablation research, including that other centers have been duplicating his work in ablating rotors and focal beats. Amazingly, some patients have had their atrial fibrillation wiped out in a matter of minutes. Watch the video or …
Read More
In this interview, Dr. Daniel Singer updates us on the new anticoagulants for atrial fibrillation stroke prevention that he presented about at Boston Atrial Fibrillation Symposium. He provided an update on rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban, and mentioned that all were better than warfarin (Coumadin) in preventing intracranial bleeding (bleeding in the …
Read More
At Boston Atrial Fibrillation Symposium 2012, Dr. Hugh Calkins, electrophysiologist at Johns Hopkins, presented the new 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation, which will replace the original guidelines that were published in 2007. Instead of simply rewriting sections that have changed, the writing committee, which was made up …
Read More
At the American Heart Association Scientific Sessions 2011, Dr. Sanjiv Narayan presented the high success rate of the FIRM trial of focal and rotor catheter ablation for atrial fibrillation. Watch the video at: Atrial Fibrillation Focal and Rotor Catheter Ablations Show High Success Rates — Video Interview with Dr. Sanjiv Narayan About the FIRM Trial
Read More
At the American Heart Association Scientific Sessions 2011, Dr. John Mandrola presented a poster on gender-specific results of atrial fibrillation ablation in a private practice setting. In this video interview with him about the poster, he mentioned that in his experience women appear to be more challenging to treat with atrial fibrillation ablation and do …
Read More
In this important video interview at Venice Arrhythmias, Professor Gregory Lip discusses the importance of the CHA2DS2-VASc scoring tool for predicting atrial fibrillation stroke risk and why aspirin is not appropriate for preventing strokes. Watch the video at: Professor Gregory Lip Discusses CHA2DS2-VASc Tool for Predicting Stroke Risk in Atrial Fibrillation — Video
Read More
The US FDA has just announced that on September 8, 2011, the FDA Cardiovascular and Renal Drugs Advisory Committee will meet to review whether to recommend approval of rivaroxaban (brand name Xarelto), an alternative to warfarin, for stroke prevention in atrial fibrillation. In this recent video interview, Dr. Elaine Hylek, a leading anticoagulant authority, discussed …
Read More
In this video interview, Dr. Hugh Calkins, electrophysiologist at Johns Hopkins, talks about the effort underway to rewrite the HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation. The new global guidelines are expected in January of 2012. Watch the video at: Johns Hopkins Electrophysiologist, Dr. Hugh Calkins, On Updating the Atrial …
Read More